Novozymes A/S (OTCMKTS:NVZMY) Cut to “Sell” at Citigroup

Citigroup lowered shares of Novozymes A/S (OTCMKTS:NVZMY) from a neutral rating to a sell rating in a report released on Thursday, Marketbeat.com reports.

Separately, Berenberg Bank upgraded shares of Novozymes A/S to a “strong-buy” rating in a research report on Tuesday, September 24th.

Novozymes A/S Price Performance

Shares of Novozymes A/S stock opened at $65.72 on Thursday. Novozymes A/S has a 1 year low of $38.83 and a 1 year high of $72.50. The firm has a market cap of $30.78 billion, a PE ratio of 41.59, a PEG ratio of 3.87 and a beta of 0.89. The company has a 50 day simple moving average of $68.16 and a two-hundred day simple moving average of $62.89.

Novozymes A/S Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, September 18th. Shareholders of record on Monday, September 9th were paid a $0.1678 dividend. The ex-dividend date was Monday, September 9th. Novozymes A/S’s dividend payout ratio is currently 41.77%.

Novozymes A/S Company Profile

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.